2027 Gastroenterology Reimbursement and Coding Update (Virtual) | November 2026-Screening, Surveillance, or Diagnostic Colonoscopy? The Details Make the Difference

Pdf Summary

The presentation reviews colorectal cancer screening coverage, coding, and billing, emphasizing that documentation of the procedure’s purpose determines how it is classified and paid.

CMS’s 2027 update to National Coverage Determination 210.3 expands coverage of qualifying noninvasive biomarker tests. Eligible asymptomatic, average-risk adults ages 45–85 may receive approved tests every three years, subject to ordering, laboratory, and test-performance requirements. Medicare coinsurance for eligible screening colonoscopies that become therapeutic is scheduled to decrease to 10% in 2027 and end in 2030.

The presentation distinguishes:
- <strong>Average-risk screening:</strong> for asymptomatic patients without qualifying risk factors.
- <strong>High-risk screening or surveillance:</strong> for asymptomatic patients with relevant personal history, family history, hereditary risk, or inflammatory bowel disease; coverage varies by payer.
- <strong>Diagnostic colonoscopy:</strong> performed to investigate symptoms or abnormalities.

A colonoscopy following a positive qualifying stool-based screening test is generally part of the preventive screening process under applicable ACA plans and Medicare rules. Coverage and cost-sharing still depend on plan type and applicable requirements; surveillance coverage is not universally guaranteed.

Key coding guidance includes using <strong>G0121</strong> for average-risk and <strong>G0105</strong> for high-risk Medicare screening; selecting ICD-10 codes that reflect the documented indication and history; and applying modifiers appropriately. <strong>KX</strong> identifies Medicare follow-up screening after a positive noninvasive test, <strong>PT</strong> applies when screening becomes diagnostic or therapeutic for Medicare, and <strong>33</strong> may identify preventive services for commercial payers. Modifiers <strong>52</strong>, <strong>53</strong>, and <strong>74</strong> address reduced or discontinued procedures.

The presenter advises practices to document screening intent clearly, avoid labeling symptomatic or surveillance procedures as routine screening, verify benefits and authorization, consult current payer policies and Medicare coverage determinations, and review explanations of benefits and denials.

Asset Subtitle

Kathleen A. Mueller, RN, CPC, QMC, QGMC, CCS-P, ICD-10 Proficient

Meta Tag

Concept Lower Endoscopy

Concept Colorectal Cancer Screening

Concept G0121

Concept G0105

Concept Diagnostic Colonoscopy

Keywords

colorectal cancer screening

CMS NCD 210.3

screening colonoscopy

average-risk screening

high-risk surveillance

diagnostic colonoscopy

Medicare billing

ICD-10 coding

modifier KX

modifier PT

Lower Endoscopy

Colorectal Cancer Screening

G0121

G0105

Diagnostic Colonoscopy